ArticleFrontiers in bioengineering and biotechnology2023

A glucose-blue light AND gate-controlled chemi-optogenetic cell-implanted therapy for treating type-1 diabetes in mice.

Chi-Yu Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.